Scientific Director, Pathology

Biogen•Cambridge, MA

5d•$220,000 - $303,000

About The Position

Biogen is seeking a motivated and passionate individual to join our team as a Director, Pathology. This role is integral to our mission of delivering transformative and safe drugs to patients by providing veterinary toxicologic pathology expertise across our diverse portfolio. You will be responsible for supporting the advancement of our pipeline by designing, executing, and interpreting toxicology studies, assessing safety risks, and contributing to project strategy across all phases of Drug Discovery and Development, as well as for marketed products. As part of an established team within the Nonclinical Safety function, you will collaborate closely with Toxicology and Study Management functions. In this high-impact position, you will play a pivotal role in enabling the delivery of first-in-class treatments and therapies that improve patient outcomes.

Requirements

DVM or equivalent; MS/PhD preferred or significant research experience in a relevant scientific discipline.
12+ years of veterinary anatomic pathology post-graduate experience in the biopharmaceutical or contract research industry.
Board certification in veterinary pathology (DACVP or equivalent) required.
Ability and experience as a toxicologic pathologist to support discovery and/or development programs.
Experience with multiple modalities, including oligonucleotides, small molecules, biologics, and antibody-drug conjugates.
Proven leadership, organizational, and time management skills, including the ability to collaboratively interact effectively with internal/external colleagues and experts for the review of anatomic pathology.
Must possess good communication and technical writing skills, capable of engaging in scientific dialogue among large groups of scientists, senior management, and external scientific experts.
Ability to express views and opinions, listen, and accept conflicting points of view.

Responsibilities

Provide pathology expertise to the design and conduct of GLP and non-GLP nonclinical safety studies to enable progression of discovery and development programs to decision points.
Conduct pathology peer reviews and provide expert evaluation of clinical and anatomic pathology data to inform study results and conclusions; conduct primary pathology evaluations as needed.
Review anatomic and clinical pathology reports; review integrated toxicology reports for finalization.
Serve as a contributing author to pathology sections of regulatory documents such as INDs, NDA/BLAs, IBs, and respond to Health Authority questions.
Contribute to and/or lead the communication of safety study results and conclusions to program teams and internal and external stakeholders.
Provide comparative medical perspective to drug development teams regarding the clinical relevance of findings from nonclinical safety assessment studies.
Contribute to initiatives aimed at improving the efficiency of pathology processes and procedures, including collaborative efforts with CRO partners.
Consult with colleagues on pathology-related results and investigate unexpected findings.
Participate in business development and due diligence evaluations for potential in-licensing, partnerships, and acquisitions of external assets.
Collaborate with colleagues on the design of investigative toxicology plans and studies.
Participate in or lead Nonclinical Safety cross-functional initiatives and special purpose subteams to address emerging trends or new approaches in toxicology and pathology.

Benefits

Medical, Dental, Vision, & Life insurances
Fitness & Wellness programs including a fitness reimbursement
Short- and Long-Term Disability insurance
A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
Up to 12 company paid holidays + 3 paid days off for Personal Significance
80 hours of sick time per calendar year
Paid Maternity and Parental Leave benefit
401(k) program participation with company matched contributions
Employee stock purchase plan
Tuition reimbursement of up to $10,000 per calendar year
Employee Resource Groups participation